Program Description & Educational Objectives

In this activity, experts in cardiology discuss the use of statin therapy to reduce cardiovascular risk.

Upon completion of this activity, participants should be better able to:

• Use up-to-date clinical information to identify those individuals who are likely to benefit from a comprehensive CAD risk management approach, including the role of statin therapy and lifestyle modifications
• Assess benefits versus risks for CAD risk reduction strategies in a variety of patients, including those with CAD and those at risk for CAD, based on current clinical evidence
• Develop CAD risk reduction goals and strategies for various patient types based on assessment of risk and clinical evidence

Target Audience

This activity has been designed to meet the educational needs of primary care physicians and other clinicians involved in the management of patients with cardiovascular risk due to atherosclerosis.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: July 21, 2011 - July 20, 2012
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Christopher P. Cannon, MD, FACC, FAHA
Associate Professor of Medicine
Harvard Medical School
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts

Christopher P. Cannon, MD, FACC, FAHA, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Accumetrics, Inc.; AstraZeneca; GlaxoSmithKline; InteKrin Therapeutics, Inc.; Merck & Co., Inc; and Takeda Pharmaceutical Company Limited.
Honoraria from AstraZeneca and Pfizer Inc for the development of independent educational symposia.
Advisory Board for Alnylam Pharmaceuticals, Inc.; Bristol-Myers Squibb; Novartis Corporation; and sanofi-aventis U.S. All funds are donated to charity.
Other Financial or Material Support from Automedics Medical Systems.

Interviewee

JoAnne M. Foody, MD, FACC, FAHA
Associate Professor of Medicine
Harvard Medical School
Director, Cardiovascular Wellness Center
Brigham and Women’s Hospital
Boston, Massachusetts

JoAnne M. Foody, MD, FACC, FAHA, has a financial interest/relationship or affiliation in the form of:
Consultant for Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc. and Lilly USA, LLC; Merck & Co., Inc; and sanofi-aventis.

CME Reviewer

Alan B. Miller, MD
Professor
Department of Medicine
Division of Cardiology
University of Florida College of Medicine
Jacksonville, Florida

Alan B. Miller, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Medtronic, Inc.
Grant/Research Support from Gilead Sciences, Inc.; and Cardioxyl Pharmaceuticals, Inc.
Speakers Bureau participant with Pfizer Inc; Forest Laboratories, Inc.; sanofi-aventis; Gilead Sciences, Inc.; and Otsuka America Pharmaceutical, Inc.

Content Director

Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education

Kathryn B. Charalambous, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.

Sponsorship, Credit & Support

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Florida College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is jointly sponsored by the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education.

This activity is supported by educational grants from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.